| Magdalene Helene Danzer-malinowski, MS | |
|
1205 S 70th St, Ste 301, West Allis, WI 53214-3167 | |
| (414) 475-2788 | |
| Not Available |
| Full Name | Magdalene Helene Danzer-malinowski |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 1205 S 70th St, West Allis, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003586587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 5163-57 (Wisconsin) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Professional Services Group Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619024262 PECOS PAC ID: 8224296454 Enrollment ID: O20120220000742 |
News Archive
How do we process numbers? A new project from the Austrian Science Fund FWF hopes to find the complex answer to this seemingly simple question by building on the recent findings of a team from Innsbruck.
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).
Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.
Researchers at the University of Utah compared the therapeutic potential of umbilical cord-derived sub-epithelial cells (UC-SECs), bone marrow-derived mesenchymal stem cells (BM-MSCs) and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) - all derived from human tissue - along with genes (S100a1 and SDF-1a) and growth factor (VEGF165) to evaluate how injected biologics might enhance cardiac function in mice modeled with myocardial infarction (MI; commonly referred to as heart attack).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Magdalene Helene Danzer-malinowski, MS 6233 39th Ave, Kenosha, WI 53142-7015 Ph: (262) 652-1004 | Magdalene Helene Danzer-malinowski, MS 1205 S 70th St, Ste 301, West Allis, WI 53214-3167 Ph: (414) 475-2788 |
News Archive
How do we process numbers? A new project from the Austrian Science Fund FWF hopes to find the complex answer to this seemingly simple question by building on the recent findings of a team from Innsbruck.
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).
Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.
Researchers at the University of Utah compared the therapeutic potential of umbilical cord-derived sub-epithelial cells (UC-SECs), bone marrow-derived mesenchymal stem cells (BM-MSCs) and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) - all derived from human tissue - along with genes (S100a1 and SDF-1a) and growth factor (VEGF165) to evaluate how injected biologics might enhance cardiac function in mice modeled with myocardial infarction (MI; commonly referred to as heart attack).
› Verified 2 days ago
Brianna A Smith, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2424 S 90th St Ste 502, West Allis, WI 53227 Phone: 414-773-4312 Fax: 414-329-5637 | |
Dr. Jody Ann Pahlavan, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11101 W Lincoln Ave, Rogers Memorial Hospital, West Allis, WI 53227 Phone: 414-327-3000 | |
Ruth A Kohnke, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6754 W Beloit Rd, West Allis, WI 53219 Phone: 414-469-4558 | |
Mrs. Kristin Lynn Arnold Miles, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11101 W Lincoln Ave, West Allis, WI 53227 Phone: 414-327-3000 | |
Mrs. Nancy Jean Goranson, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11101 W Lincoln Ave, Rogers Memorial Hospital, West Allis, WI 53227 Phone: 414-203-4480 Fax: 414-328-3737 | |
Dr. Nathan David Glassman, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2448 S 102nd St, Suite #270, West Allis, WI 53227 Phone: 414-444-9811 Fax: 414-444-9822 |